The Big Shift
China’s maternity and baby market is undergoing a fundamental transformation — from volume to value. The number of babies born in China fell to 9.02 million in 2025, down from 10.48 million in 2023 and 12 million in 2020. But spending per child has risen sharply: total market value reached an estimated USD 52 billion in 2025, up 18% from 2020 levels. The math is straightforward — fewer babies, but parents are spending more on each one. For foreign brands in infant formula, childcare products, early education, and maternal health services, this creates a different kind of opportunity than the volume-driven market of a decade ago.
Why It Matters
Three structural trends define the market today. First, China’s fertility rate of 1.09 children per woman (2025, NBS) is among the world’s lowest, and government incentives — from baby bonuses to extended parental leave — have so far failed to reverse the decline. Second, the urban middle class now accounts for 62% of total baby product spending despite representing only 38% of births, making premiumization the dominant growth strategy. Third, new policy signals from the State Council in early 2026 point to further deregulation of infant formula registration and maternal health service licensing — sectors that have been tightly restricted since the 2008 melamine scandal.
For foreign brands, the window is particularly interesting because domestic competitors face headwinds of their own. China’s local baby formula brands held 68% of the market in 2025, up from 45% in 2018, but many smaller domestic producers are struggling with the updated National Food Safety Standard (GB 10765-2025) which raised quality requirements effective January 2026. Consolidation is coming, and well-capitalized foreign brands with established regulatory compliance systems stand to gain — similar dynamics to what we’ve observed with premium foreign brands navigating China’s shifting consumer market.
The Details
Segment Breakdown: Where the Money Is
Infant formula and baby food (38% of market, USD 19.8 billion): This remains the largest and most regulated segment. Foreign brands hold 32% market share, concentrated in premium (RMB 350–500 per 800g can) and super-premium (RMB 500+) tiers. The 2025 formula registration reforms reduced the new product approval timeline from 24 months to 12 months for products meeting GB 10765-2025, a significant improvement for foreign manufacturers with compliant facilities.
Baby care and personal products (22%, USD 11.4 billion): Diapers, wipes, and skincare. Foreign brands dominate the premium diaper segment (Huggies and Pampers hold 54% combined share of the premium tier), but domestic brands have captured over 70% of the mid-range market through aggressive DTC e-commerce strategies on Douyin and Pinduoduo.
Early childhood education (15%, USD 7.8 billion): The fastest-growing segment at 12% year-over-year. The “double reduction” policy (双减政策, shuāngjiǎn zhèngcè) that cracked down on after-school tutoring in 2021 explicitly exempted early childhood education for children under 6, creating a regulatory safe zone for foreign brands offering Montessori, Reggio Emilia, and bilingual programs.
Maternal health and services (18%, USD 9.4 billion): Concierge maternity hospitals, postpartum confinement centers (月子中心, yuèzǐ zhōngxīn), and fertility services. Foreign-invested maternity hospitals in Shanghai and Beijing report occupancy rates above 85% for premium delivery packages (RMB 80,000–200,000), with waiting lists extending 4–6 months.
Regulatory Hurdles Foreign Brands Face
The main challenges are threefold. First, infant formula and baby food require SAMR (State Administration for Market Regulation) formula registration, a process that demands 12–18 months of documentation, factory inspection, and clinical data for any new product. Second, cross-border e-commerce (CBEC) channels — which 41% of foreign baby brands use as their primary China entry route — face new customs clearance requirements under the 2025 revised CBEC rules, including stricter ingredient documentation for imported baby food. Third, advertising restrictions under China’s Advertising Law prohibit using medical terminology for baby products and restrict before-and-after claims for maternal health services.
What You Should Do
- Enter through cross-border e-commerce first. CBEC channels on Tmall Global and JD Worldwide remain the lowest-risk entry path. Use CBEC to validate demand, build brand awareness, and establish regulatory documentation before committing to a physical WFOE registration. This approach aligns with broader trends we’ve analyzed in China’s two-speed economy and where foreign businesses can win.
- Target premium, not mass-market. The volume is in the premium tier. Mid-range baby products face brutal price competition from domestic brands with lower cost structures. Premium products command 3–5x margins and face fewer domestic competitors in most sub-segments.
- Plan for SAMR registration early. If your product requires formula registration (infant formula, baby food, supplements), start the documentation process 18 months before your planned China market launch. The timeline is non-negotiable and has not been meaningfully shortened despite the 2025 reforms.
- Focus on tier-1 and tier-2 cities. 78% of premium baby product spending is concentrated in China’s top 30 cities, with Shanghai, Beijing, and Guangzhou alone accounting for 34%. Rural expansion can wait until brand recognition is established.
One Data Point
The number to remember: 62% — the share of total baby product spending coming from urban middle-class families, despite representing only 38% of births. China’s baby market is no longer about volume. It is about value per child, and that value is concentrated in cities where parents have disposable income and are willing to pay a premium for safety, quality, and brand heritage.
— China Gateway 360 —
Remote China market entry support, built around execution.
